Paul Mahon
2016
In 2016, Paul Mahon earned a total compensation of $7.6M as Executive Vice President and General Counsel at United Therapeutics, a 11% decrease compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,006,819 |
|---|---|
| Non-Equity Incentive Plan | $413,764 |
| Option Awards | $5,243,288 |
| Salary | $942,724 |
| Other | $21,600 |
| Total | $7,628,195 |
Mahon received $5.2M in option awards, accounting for 69% of the total pay in 2016.
Mahon also received $1M of change in pension value and nonqualified deferred compensation earnings, $413.8K in non-equity incentive plan, $942.7K in salary and $21.6K in other compensation.
Rankings
In 2016, Paul Mahon's compensation ranked 809th out of 14,075 executives tracked by ExecPay. In other words, Mahon earned more than 94.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 809 out of 14,075 | 94th |
Division Manufacturing | 258 out of 5,486 | 95th |
Major group Chemicals And Allied Products | 66 out of 1,900 | 97th |
Industry group Drugs | 44 out of 1,543 | 97th |
Industry Pharmaceutical Preparations | 36 out of 1,173 | 97th |
Source: SEC filing on April 28, 2017.
Mahon's colleagues
We found five more compensation records of executives who worked with Paul Mahon at United Therapeutics in 2016.
2016
Roger Jeffs
United Therapeutics
Chief Executive Officer
2016
Martine Rothblatt
United Therapeutics
Chief Executive Officer
2016
Michael Benkowitz
United Therapeutics
Chief Operating Officer
2016
James Edgemond
United Therapeutics
Chief Financial Officer
2016
David Zaccardelli
United Therapeutics